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Aims: Periodontitis is an independent risk factor for cardiovascular disease, but the
mechanistic link is not fully understood. In atherosclerotic cardiovascular disease,
monocytes can adopt a persistent hyperresponsive phenotype, termed trained
immunity. We hypothesized that periodontitis-associated bacteria can induce trained
immunity in monocytes, which subsequently accelerate atherosclerosis development.
Materials and Methods: We combined in vitro experiments on human primary
monocytes and in vivo techniques in patients with periodontitis to test this hypothesis.
Adherent peripheral blood mononuclear cells (PBMCs) were transiently exposed in vitro to
Porphyromonas gingivalis for 24 hours, and restimulated with lipopolysaccharide (LPS) or
Pam3CysK4 (P3C) six days later, to measure interleukin-6 (IL-6) and tumor necrosis factor
a (TNFa) production. In an exploratory observational study, patients with severe
periodontitis (63 ± 6 years, n=14) and control subjects with no-to-mild periodontitis
(54 ± 10 years, n=14) underwent venipuncture and 2’-deoxy-2’-[18F]fluoro-D-glucose
positron-emission-tomography ([18F]FDG PET/CT) scanning.
Results: When adherent peripheral blood mononuclear cells (PBMCs) were transiently
exposed in vitro to Porphyromonas gingivalis for 24 hours, and restimulated with LPS or
P3C six days later, IL-6 and TNFa production was significantly increased (TNFa/P3C,
p<0.01). Circulating leukocytes, IL-6 and interleukin-1 receptor antagonist (IL-1Ra)
concentrations were generally higher in patients compared to controls (leukocytes:
p<0.01; IL-6: p=0.08; IL-1Ra: p=0.10). Cytokine production capacity in PBMCs after
24h stimulation revealed no differences between groups. [18F]FDG PET/CT imaging
showed a trend for increased [18F]FDG-uptake in the periodontium [mean standard
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uptake value (SUVmean), p=0.11] and in femur bone marrow (SUVmean, p=0.06), but no
differences were observed for vascular inflammation. Positive correlations between severity
of periodontitis, measured by The Dutch Periodontal Screening Index and pocket depth,
with circulating inflammatory markers and tissue inflammation were found.
Conclusions: P. gingivalis induces long-term activation of human monocytes in vitro
(trained immunity). Patients with severe periodontitis did have signs of increased systemic
inflammation and hematopoietic tissue activation. However, their circulating monocytes
did not show a hyperresponsive phenotype. Together we suggest that trained immunity
might contribute to local periodontal inflammation which warrants further investigation.
Keywords: periodontitis, Porphyromonas gingivalis, trained immunity, inflammation, cardiovascular disease
INTRODUCTION
Periodontitis (PD) is an independent risk factor for cardiovascular
disease (CVD) (1, 2). Unravelling the mechanistic link between
PD and CVD is of great public health importance due to their high
prevalence and economic burden (3, 4). Despite ongoing research,
a comprehensive understanding of this association is still
lacking (5).
PD and CVD are chronic low-grade inflammatory diseases,
driven by the activation of innate immune cells. In
atherosclerosis, which is the main cause of CVD, monocytes
and macrophages play a key role in the initiation, progression,
and destabilization of atherosclerotic plaques (6). In PD,
microbial dysbiosis and local inflammation co-develop in a
reciprocally reinforced manner (7). Porphyromonas gingivalis is
a keystone periodontal pathogen driving microbial dysbiosis in
PD (8, 9), and is also suggested to be involved in atherosclerotic
CVD. It was isolated from human atherosclerotic plaques (1),
and reported to modulate immune cell function (10). In mice, P.
gingivalis-induced PD led to atherosclerosis with enhanced
vascular wall inflammation (11). We now propose that a novel
mechanism of innate immune cell activation, called trained
immunity, contributes to the association between PD and CVD.
Trained immunity describes the observation that monocytes/
macrophages can build immunological memory after encountering
a pathogen, resulting in a persistent hyperresponsive phenotype.
Increased cytokine production capacity is the hallmark of trained
immunity. It provides host protection against recurrent infections,
but in chronic inflammatory diseases, such as atherosclerosis, it can
contribute to the disease pathophysiology (12). Trained immunity
can be induced by brief exposure to micro-organisms, but also with
endogenous atherogenic stimuli. In humanmonocytes, exposure to
oxidized low-density lipoprotein (oxLDL) induces a persistently
enhanced cytokine response and increased foam cell formation
(13). Trained immunity develops through distinct epigenetic and
metabolic reprogramming (12).
In view of the association between PD and CVD, we now
hypothesize that P. gingivalis as a keystone periodontal pathogen
can induce trained immunity in vitro, and that monocytes
isolated from patients with PD have a hyperresponsive




P. gingivalis strains ATCC 33277 and W83 (kindly provided by
ACTA, Amsterdam, The Netherlands) were cultured on blood
agar plates under anaerobic conditions at 37°C. At day 7,
colonies were transferred to anaerobe basal broth (CM0957,
ThermoFisher, Waltham, USA) and cultured for 24h until they
reached mid-log growth. Gram staining confirmed purity of the
cultures. The bacterial cultures (OD690 0.1) were heat-inactivated
at 60°C for 60min.
PBMC Isolation
Buffy coats were obtained from healthy donors after written
consent (Sanquin Blood Bank, Nijmegen, the Netherlands).
Peripheral blood mononuclear cells (PBMCs) were isolated
using density centrifugation over Ficoll-Paque PLUS (GE
Healthcare Biosciences, Chicago, USA). Cells were resuspended
in Dutch modified RPMI culture medium (Invitrogen, CA, USA)
supplemented with 2mmol/L glutamine, 10mg/mL gentamicin
and 1mmol/L pyruvate.
Trained Immunity Model
A validated trained immunity experimental design was used (14,
15). After 1h incubation with 5x105 PBMCs per well, cells were
washed thrice to remove non-adherent cells in flat-bottom 96-
well plates (Corning, NY, USA). Adherent monocytes were
stimulated with 1x104/mL P. gingivalis W83, 1x104/mL P.
gingivalis ATCC, or RPMI only. After 24h incubation, the cells
were washed with warm PBS and incubated in culture medium
with 10% pooled human serum. At day 6, cells were restimulated
with RPMI, 10ng/mL Escherichia coli lipopolysaccharide (LPS;
serotype 055:B5 Sigma-Aldrich, St. Louis, USA), and 10mg/mL
Pam3CysK4 (P3C; EMCMicrocollections, Tübingen, Germany).
At day 7, supernatants were collected and stored at −20°C.
In separate experiments, P. gingivalis stimulation was
combined with freshly oxidized LDL [10µg/mL, prepared as
described previously (16)] for 24h in adherent monocytes. In
brief, LDL was isolated from healthy volunteers under sterile
conditions and stored at -80 with saccharose and EDTA to
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prevent oxidation. Upon thawing, LDL was dialyzed with sterile
PBS for 7h and oxidated overnight with filter sterilized copper
sulfate. Contamination by endotoxins has been previously ruled
out by the original protocol (13, 16). After 24h stimulation, the
stimuli were washed away and the similar protocol as noted
above was followed.
Cytotoxicity
Cytotoxicity was determined after 24h of incubation with P.
gingivalis using a lactate dehydrogenase cytotoxicity assay (LDH;
CytoTox-96-Non-Radioactive-Cytotoxicity-Assay, Promega,
USA) on fresh supernatants.
Foam Cell Formation
Foam cell formation was evaluated after 4h starvation and 24h
oxLDL (25µg/mL) exposure at day 6 of the trained immunity
experiment. On day 7, Oil Red O staining was performed on
adherent macrophages. Intracellular ApoB concentration was
measured using enzyme-linked immunosorbent assay (ELISA)
as described in (17).
Cytokine Measurements
Cytokine production in supernatants was determined using
DuoSet ELISA for TNFa and IL-6 according to the
manufacturers’ instructions (R&D Systems, Minneapolis, USA).
In Vivo Methods
Study Participants
Participants (40-80 years) were recruited among patients of the
Dentistry department of Radboud University Medical Center,
the Netherlands from 03-2018 till 02-2019. At the department of
Dentistry standard dental care is provided and the patients
represent the average population in the area, i.e. they are not
referred because of dental problems. Exclusion criteria were
previous CVD, auto-immune or auto-inflammatory diseases
(including diabetes mellitus), chronic immunomodulatory drug
use, chronic kidney disease (MDRD<45ml/min) or liver disease
(ALAT>135U/l). Additionally, participants with an infection
(>38,5°C or antibiotic treatment), hospital admission, or
vaccination within 1-month prior study entry were excluded.
We attempted to match control participants based on age, sex,
body mass index (BMI) and smoking. The study protocol was
approved by the Institutional Review Board Arnhem/Nijmegen,
the Netherlands (NL61840.091.17) and conform STROBE
Guidelines. All participants gave written informed consent.
Clinical Periodontal Assessment
The Dutch Periodontal Screening Index (DPSI) and probing
pocket depth (PPD) were recorded by an experienced
periodontist [AP]. Subjects with DPSI scores 0-2 were classified
as having no PD (category A), those with DPSI score 3- as having
mild PD (category B), and subjects with DPSI scores 3+ and 4 as
having severe PD (category C) (18). The presence of alveolar bone
loss on paired bitewings, defined as >2 mm distance between the
cement-enamel junction and alveolar bone crest (19) was used to
confirm the clinical diagnosis. Subjects with DPSI category C and
advanced alveolar bone loss were assigned to the patient group,
i.e. participants with severe PD. Subjects with DPSI category A
and B without radiographic alveolar bone loss were assigned to
the control group, i.e. participants with no-to-mild PD, which is
representative for the normal population in this age category.
Defined by the New Periodontal classification of 2018 (20),
patients had PD-stage II-IV, whilst controls had gingivitis or
PD-stage I.
Cardiovascular Risk Assessment
Blood pressure was measured according to AHA guidelines (21).
Fasting total cholesterol (Tchol), high-density lipoprotein
cholesterol (HDLc), and triglycerides (TG) were measured
using standardized methods, and LDL cholesterol (LDLc) was
calculated with the Friedewald formula.
PBMC Isolation and Stimulation
PBMCs were isolated by Ficoll-Paque density gradient
centrifugation (GE Healthcare) and resuspended in supplemented
RPMI. Cell composition was evaluated by Sysmex analyzer
(Sysmex). Per well, 5x105 PBMCs were stimulated for 24h in
triplicate in round-bottom 96-well plates (Corning) with the
following stimuli to assess the innate immune response: RPMI,
10ng/mL LPS and 10mg/mL P3C. Simultaneously, to assess the
adaptive immune response, PBMCs were stimulated in duplicate
for 7days with RPMI, 1×106/mL Candida albicans conidia (UC820
strain), or 1x106/mL Staphylococcus aureus (ATCC29213 strain)
both with 10% human pool serum. After the incubation periods of
24h and 7days, supernatants were stored after plate centrifugation
at −80°C.
Cytokine Measurements
Cytokine and chemokine concentrations were determined in
supernatants using DuoSet ELISA for TNFa, IL-6, IL-8, IL-10,
IL-1b, IL-17 and IL-22 (R&D), and interferon gamma (IFN-g)
(Sanquin). Plasma hsCRP concentrations were obtained (R&D).
Circulating IL-1b, IL-1Ra, IL-6 and IL-18 concentrations were
sensitively measured using SimplePlex cartridge on the Ella
platform (Protein Simple, San Jose, USA).
Flow Cytometry
Circulating immune cells and monocyte subpopulations were
determined by their expression markers using a CYTOflex flow
cytometer (Beckman Coulter). 50 µL EDTA blood was stained
after the lysis-no-wash strategy (BD Pharm Lyse lysing buffer,
Becton Dickinson) by monoclonal antibodies CD45 Krome
Orange ([KO], clone J33; Beckman Coulter), HLA-DR PE
(clone immu-357; Beckman Coulter), CD14 PC7 (clone 61D3
Bioscience), CD16 FITC (clone CB16; eBioscience), CD3 APC-
Alexa750 (clone UCTH1; Beckman Coulter), CD56 APC (clone
N901; Beckman Coulter), CD192 Brilliant Violet421 ([BV421]
clone 48607; Becton Dickinson), CD11b BV785 (clone ICRF44;
Biolegend), CD41 PC5.5 (clone Hip8; Biolegend) and measured
with CytoFLEX flow cytometer (Beckman Coulter).
Single cells were analyzed by manual gating using Kaluza v2.1
software (Beckman Coulter) and unsupervised computational methods
in parallel using FlowJo v10.6.2 software (Beckton Dickinson).
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The gating strategy applied is shown inAppendix Figure 1, gates
were set with the fluorescence-minus-one method (22, 23). In
short, monocytes were selected based on CD45+ HLA-DR+ and
monocyte scatter properties, then CD3+ T-lymphocytes and
CD56+ NK-cells were excluded, and monocyte subsets were
identified in the CD14/CD16 plot as percentage of gated. Data
was analyzed with Kaluza 2.1 software (Beckman Coulter).
Characterization of monocytes subsets is according to current
recommendations (22, 23).
For unsupervised computation analyses, data files were
randomly down sampled to 10,000 events per file and
subsequently concatenated to a single file containing all events.
Controls and patients were labelled accordingly to allow separation
after analysis. Unsupervised clustering was performed on the
expression values of all markers using the tSNE plugin in FlowJo
v10.6.2 software (Becton Dickinson), using 300 iterations and a
perplexity of 20.Manual gating of cell populations (based on gating
strategy) was used to identify cell populations and check the
separation quality of the unsupervised clustering. The
contribution of periodontitis to circulating cell populations in the
total tSNE was inspected by separating the patient and control
group in two figures (Figure 3). Visual differences were confirmed
by manual gating and statistical analysis.
[18F]FDG PET and Low-Dose CT Scanning
After adhering to a 24h low-carbohydrate diet and 6h of fasting,
participants underwent 2’-deoxy-2’-[18F]fluoro-D-glucose
positron-emission-tomography ([18F]FDG PET) with low-dose
non-contrast enhanced CT on a dedicated Siemens Biograph
40mCT scanner (Siemens Healthineers, Erlangen, Germany).
Analyses were performed on reconstruction settings according
to European guidelines (24) using Inveon Research Workspace
v4.2 software. See supplement for details.
Periodontal [18F]FDG-uptake was determined in the left and
right periodontium of maxilla-to-mandible (Figure 4A,Appendix
Figure 2). Vascular [18F]FDG-uptake was determined in the aorta
ascendens, aorta descendens, abdominal aorta, the left and right
common carotid arteries, and the left and right iliac arteries
(Figure 4B, illustration). Hematopoietic [18F]FDG-uptake was
assessed in the spleen, lumbar vertebrae L2/L3, and the left and
right medullary femur cavity (Figure 4C, illustration). The mean
standardized uptake value (SUVmean) was calculated after
correction for weight and [18F]FDG-dose (MBq). The target-to-
background ratio (TBR) was calculated as the ratio of vascular wall
SUVmean and arterial bloodpool SUVmean. Hematopoietic tissue
TBR was expressed as ratio of liver SUVmean.
Statistical Analysis
In vitro data are reported as mean ± SEM. P. gingivalis-trained
cells were compared to RPMI-incubated control cells using
Wilcoxon signed-rank test. The in vivo study is exploratory,
hence no sample size calculation is performed. In vivo
continuous variables are reported as mean ± SD or median
[interquartile range], depending on the data distribution.
Normal distribution of the data was checked with the Shapiro-
Wilk test, when the p-value reached <0.05 this assumption was
violated. Patients and controls were compared for continuous
variables using independent samples T-test (if normally
distributed) or Mann-Whitney U test (if not normally
distributed). Categorical variables are presented as percentage
(number) and were compared using Χ2-test. For all study
outcomes, a one-way ANCOVA was conducted to control for
age differences between patients and controls. Beforehand,
outliers were removed with > ± 3SD of Z-scores and thereafter
log(10)-transformed. Missing values were not imputed. A two-
sided p-value <0.05 was considered statistically significant. All
data were analyzed using SPSS v25.0 (Chicago, USA).
RESULTS
P. gingivalis Induces Trained Immunity
In Vitro
The in vitro experiments with P. gingivalis ATCC and W83
strains are illustrated in Figure 1A. The production of IL-6 and
TNFa after restimulation was significantly increased compared
to the RPMI-incubated control cells (Figure 1B, noted in fold
change p<0.05). Restimulation with P3C, a TLR2 agonist, resulted
in the strongest augmentation of the cytokine response with a two-
fold induction. The absolute cytokine production is shown is
Appendix Table 1.
In P. gingivalis-trained macrophages, foam cell formation
seemed to be increased as visualized by Oil Red O staining
(Figure 1C). Quantification of the intracellular lipid uptake
(ApoB) did not show differences (p=0.20, data not shown).
BothoxLDLandP. gingivalis canbe found in lowconcentrations
in the periodontium (25). Costimulation with P. gingivalis and
oxLDL in the first 24h resulted in a strong amplification of cytokine
production upon restimulation compared to the RPMI-exposed
control. The induction of trained immunity by combined
stimulation was not stronger compared to oxLDL training alone,
although there was a trend for ATCC to further potentiate LPS-
induced TNFa release (Figure 1D, p=0.12). Costimulation did not
influence cell viability (Figure 2).
Patients With Severe Periodontitis Have
Increased Systemic Inflammation Which
Correlates With Tissue Inflammation
Baseline Characteristics
We included participants with severe PD (DPSI 3.9 ± 0.2, n=14,
‘patients’) and participants with no-to-mild PD (DPSI 2.9 ± 0.3,
n=14, ‘controls’),which is a representative of the general population
(Table1).Patientswereolder thancontrols (mean63±6versus54±
10 years, p<0.05), but there was no significant different in classical
cardiovascular risk factors. Patients only had a higher previous
tobacco exposure (15.8 ± 18.2 versus 4.5 ± 5.7 pack years, p<0.05),
but current smoking behavior was similar. Age is known to impact
immune cell function (26) and future cardiovascular risk, therefore
we corrected all comparisons for age.
Systemic Inflammatory Markers
Higher circulating leukocytes (median 6.1 versus 5.6 106/mL,
p<0.01) and a trend for higher lymphocytes numbers (1.8 versus
1.7 106/mL, p=0.06) were found in patients compared to controls
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after age correction. In addition, a tendency for higher
concentrations of circulating pro-inflammatory IL-6 and anti-
inflammatory IL-1Ra cytokines were observed, but after age
correction the statistical significance was lost (IL-6: 2.0 versus 1.4
pg/mL, p=0.08; IL-1Ra: 247 versus 171 pg/mL, p=0.10) (Table 2).
Using flow cytometry, circulating immune cell populations
were further identified based on their expression markers
(Figure 3). Unsupervised t-Stochastic Neighbor Embedding
(tSNE) analysis showed a large overlap between both groups
with potentially interesting differences in cell populations
(Figure 3B). The most distinct population was a smaller
cluster of T-cells with high CD41 expression in patients
compared to controls (Figure 3C, arrows). Further analysis of
this lymphocyte-platelet interacting cell population was not
allowed as the flow cytometry panel used was designed for
monocyte activation analysis and did not include further T-cell
markers. Manual gating of these populations and statistical
analysis also revealed high similarity between groups (Table 2).
Cytokine Production Capacity
No significant difference in the cytokine production capacity of
PBMCs between patients and controls was observed (Table 3),
for both 24h stimulation with LPS or P3C stimulation (i.e. innate
immune response) and 7 day stimulation with whole pathogens
C. albicans or S. aureus (i.e. adaptive immune response).
Periodontal, Hematopoietic, and Arterial
Wall Activation on [18F]FDG PET/CT
[18F]FDG PET/CT imaging results are discussed before (i.e. raw
data) and after correction for age. The figures display raw data
with age-corrected p-values. Increased [18F]FDG-uptake in
periodontium was observed in patients compared to controls
(SUVmean 1.70 versus 1.49, p<0.05). After age correction, the
statistical significance was diminished (Figure 4A, p=0.11). The
SUV in ascending aorta, carotid and iliac arteries and main
hematopoietic regions were higher in patients, including the
blood pool used to calculate target-to-background ratios (TBR)
(Appendix Table 2). Age correction resulted in the loss of
statistical significance for arterial wall [18F]FDG-uptake
(Figure 4B). A trend for higher [18F]FDG-uptake in
hematopoietic tissue of patients remained for the femur bone
marrow (SUVmean 0.88 versus 0.58, p=0.06) (Figure 4C).
The TBR values showed no statistically significant difference




FIGURE 1 | Trained immunity by P. gingivalis. (A) Overview of trained immunity model. Adherent monocytes were trained for 24h on day 1 with Pg or Pg with
oxLDL (10µg/mL). After 24h the training stimulus was washed away, the cells were rested for 6 days in supplemented RPMI after which the cells were restimulated
on day 6 with RPMI, LPS, or P3C for 24h (without oxLDL) to measure cytokine production, or they were exposed to oxLDL (25 µg/mL) for 24 hours to induce foam
cell formation. On day 7, TNFa and IL-6 concentrations were measured in the supernatants. (B) P. gingivalis induces trained immunity as shown by the increased
fold change of TNFa and IL-6 (n=20, *p < 0.05, **p < 0.01). (C) Foam cell formation by P. gingivalis using Oil Red O staining. Magnification x40, scale bar 50µm
(n=6, representative picture is shown). (D) P. gingivalis in combination with oxLDL exposure for 24h on day 1 increased training response (n = 6, *p < 0.05). Data are
presented as fold change with mean ± SEM. P. gingivalis-trained cells were compared to RPMI-incubated control cells at day 1 after restimulation with LPS or P3C
at day 6. Wilcoxon signed-rank test. Pg, P. gingivalis; oxLDL, oxidized LDL; W83, Pg W83 strain; ATCC, Pg ATCC strain; RPMI, medium control.
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trend for femur bone marrow activation was observed in patients
after age correction (TBRmean 0.40 versus 0.31, p=0.08)
(Appendix Table 3).
Periodontitis Severity Correlates
With Circulating Markers and
Tissue Inflammation
The severity of PD, either measured by DPSI or PPD, showed
strong positive associations with circulating markers IL-6 and IL-
1Ra, and with iliac artery vascular wall and femur hematopoietic
tissue [18F]FDG-uptake (Figure 5 and Appendix Table 4). For
example, the DPSI score strongly correlated with the number of
circulating leukocytes (p<0.01) and mildly correlated with
vascular wall inflammation in the iliac arteries (p=0.10).
Also the mean PPD associated with circulating IL-6
concentrations (p<0.05), periodontal tissue inflammation
(p<0.01) and splenic tissue activity (p<0.05). For circulating
markers IL-1b, IL-18, CRP, circulating cell types, and other
vascular regions no association with PD was found.
DISCUSSION
Our aim was to explore the induction of trained immunity as a
plausible mechanistic link between PD and atherosclerosis. In
vitro, we showed that P. gingivalis induces trained immunity in
human monocytes, in terms of an augmented cytokine
production capacity. In vivo, patients with severe PD had signs
FIGURE 2 | Cytotoxicity of stimuli. Cell viability after 24h P. gingivalis and
oxLDL costimulation (n = 6, *p < 0.05) measured with LDH cytotoxicity assay.
Data are presented with mean ± SEM, p-values using Wilcoxon signed-rank
test. oxLDL, oxidized LDL; W83, Pg W83 strain; ATCC, Pg ATCC strain;
RPMI, medium control; + control, positive control for cell death.
TABLE 1 | Baseline characteristics.
Demographics Controls (n=14) Patients (n=14)
DPSI, 0-4 2.9 ± 0.3 3.9 ± 0.2**
Mean PPD, mm 3.7 ± 0.6 5.0 ± 1.3**
Deepest PPD, mm 4.6 ± 0.7 6.4 ± 1.6**
Age, years 54 ± 10 63 ± 6*
Sex, % men 57 (8) 36 (5)
BMI, kg/m2 24.9 ± 3.5 28.0 ± 6.5
SBP, mmHg 130 ± 17 137 ± 17
DBP, mmHg 80 ± 7 89 ± 12
Hypertension, % (n) 43 (6) 64 (9)
Alcohol consumption, 0-8 3.3 ± 1.7 2.9 ± 1.4
Current smoking, % (n) 14 (2) 7 (1)
Smoking, packyears 4.5 ± 5.7 15.8 ± 18.2*
Anti-hypertensive treatment, % (n) 14 (2) 29 (4)
Lipid lowering therapy, % (n) 7 (1) 29 (4)
Fasting glucose, mmol/L 5.1 ± 0.4 5.4 ± 0.4
Creatinine, mmol/L 79 ± 12 75 ± 10
Tchol, mmol/L 4.96 ± 0.47 5.18 ± 0.76
LDLc, mmol/L †2.65 ± 0.44 2.90 ± 0.67
HDLc, mmol/L 1.41 ± 0.47 1.44 ± 0.37
TG, mmol/L 1.92 ± 1.19 1.90 ± 0.88
nHDLc, mmol/L †3.52 ± 0.73 3.76 ± 0.84
Demographics are reported as mean ± SD or % (number of participants) in control
participants (n = 14) and participants with periodontitis (n = 14). Normally distributed data
were analyzed using independent samples T-test, qi-square test was used for categorial
data. Anti-hypertensive treatment includes beta-blockers, ACE-inhibitors, ARB’s and
thiazide diuretics. Alcohol consumption is the sum of alcohol consumption frequency
(0-4, ranging from never: 0 to >4x/week:4) and alcohol consumption quantity per occasion
(0-4, ranging from 1-2 drinks:0 to >10 drinks:4) based on the Alcohol Use Disorders
Identification Test questions. †Data is missing for 1 participant. * indicates P < 0.05, **P <
0.01. PPD, probing pocket depth. Bold values express differences of interest, with a p-
value <0.10.
TABLE 2 | Circulating cell types and cytokines/chemokines.
Cell types Controls Patients
WBC, 106/mL 5.6 [4.5-6.2] 6.1 [5.5-7.1]**
Neutrophils, 106/mL 3.3 [2.7-3.8] 3.2 [3.0-4.3]
Lymphocytes, 106/mL 1.7 [1.5-2.1] 1.9 [1.6-2.2]^
Monocytes, 106/mL 0.4 [0.3-0.5] 0.5 [0.4-0.6]
Monocytes, % 7.1 [6.1-8.5] 7.1 [6.5-8.5]
Eosinophils, 106/mL 0.14 [0.08-0.19] 0.10 [0.07-0.15]
Basophils, 106/mL 0.03 [0.02-0.04] 0.04 [0.03-0.05]
Classical monocytes, %gated 82 [75-84] 80 [75-85]
Intermediate monocytes, %gated 8.2 [6.3-10] 9.0 [7.0-13]
Nonclassical monocytes, %gated 10 [9.4-14] 10 [8-14]
CCR2+ monocytes, %gated 84 [80-88] 86 [81-89]
CD11b+ monocytes, %gated 87 [67-96] 91 [88-94]
CD41+ monocytes, %gated 7.4 [6.0-9.28] 7.0 [6.0-9.5]
Cytokines & chemokines
IL-1b, pg/mL 0.17 [0.14-0.24] 0.17 [0.13-0.21]
IL-1Ra, pg/mL 171 [145-239] 247 [188-428]^
IL-6, pg/mL 1.4 [0.9-1.9] 2.0 [1.6-3.0]^
IL-18, pg/mL 159 [120-189] 182 [136-244]
hsCRP, µg/mL 0.7 [0.3-1.8] 0.7 [0.4-1.3]
Circulating cells/markers are reported as median with [interquartile ranges] in control
participants (n = 14) and participants with periodontitis (n = 14). 10 samples under IL-1b
lowest detection limit of 0.16 pg/mL. One sample under IL-6 lowest detection limit of 0.70
pg/mL. P-values are age corrected using ANCOVA. ^ indicates P < 0.10, for lymphocytes
p = 0.06, IL-6: p = 0.08, IL-1Ra: p = 0.10. **P < 0.01. WBC: white blood cell counts. Bold
values express differences of interest, with a p-value <0.10.
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TABLE 3 | Cytokine production capacity.
24-hour stimulation Controls Patients
LPS stimulated PBMCs
TNFa, pg/mL 637 [414-1204] 324 [212-976]
IL-1b, pg/mL 5222 [3893-11317] 6950 [4808-11264]
IL-6, ng/mL 13.1 [7.9-15.8] 12.0 [6.9-20.8]
IL-8, ng/mL 107 [89-123] 110 [68-139]
IL-10, pg/mL 182 [91-295] 110 [59-236]
P3C stimulated PBMCs
TNFa, pg/mL 557 [88-1338] 338 [145-681]
IL-1b, pg/mL 4216 [3112-5929] 5230 [3982-6720]
IL-6, ng/mL 13.2 [11.3-17.4] 13.6 [10.8-17.6]
IL-8, ng/mL 148 [129-189] 146 [126-185]
IL-10, pg/mL 47 [47-131] 55 [47-97]
7-day stimulation
C. albicans stimulated PBMCs
IFNg, pg/mL 1500 [727-1500] 1276 [625-1500]
IL-17, pg/mL 1509 [631-2811] 1033 [575-2137]
IL-22, pg/mL 5855 [2723-9233] 3803 [1120-9906]
S. aureus stimulated PBMCs
IFNg, pg/mL 1500 [604-1500] 1040 [508-1500]
IL-17, pg/mL 171 [39-401] 77 [39-127]
IL-22, pg/mL 472 [108-661] 189 [85-787]
Cytokine production capacity of PBMCs in control participants (n = 14) and participants with periodontitis (n = 14) after 24h stimulation with LPS or P3C to assess the innate immune





FIGURE 3 | Unsupervised t-Stochastic Neighbor Embedding (tSNE) analysis. Unsupervised tSNE plots show the contribution of each expression marker in each cell type.
(A) The overview presents the identified circulating cell types, see the legend within the table. (B) The distribution of each expression marker per cell type. The color depicts
the MFI expression of each marker (blue: low MFI, red: high MFI). (C) The difference between control participants (n=14) and participants with periodontitis (n=14) is shown
for each cell type. The arrow indicates a visual smaller group of platelet-lymphocyte complexes in the periodontitis’ group compared to the control group.
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of systemic inflammation, with higher circulating leukocyte
counts. However, their circulating monocytes did not show a
hyperresponsive phenotype. Patients appeared to have
periodontal and hematopoietic tissue activation as visualized
by [18F]FDG PET/CT, although this was not significant after
age correction, which correlated with PD severity.
First, we set up an in vitro study using a validated trained
immunity protocol (14). Previously we showed that exposure of
human monocytes to microbial stimuli, including Candida
albicans and Bacille Calmette-Guérin (BCG), and endogenous
atherogenic stimuli, including oxLDL and catecholamines, leads
to an augmented cytokine production in response to restimulation
(27, 28) (13, 29, 30). In the current study, two different P.
gingivalis strains were also capable of inducing trained
immunity. Two P. gingivalis strains with different virulent rates,
based on its capacity to invade endothelial cells (10), were chosen
to investigate the trainings effect in healthy donors. Interestingly,
the more virulent W83 strain induced a stronger trained
immunity response than ATCC. The augmented cytokine
production was most pronounced after restimulation with P3C,
a TLR2 agonist, compared to LPS, a TLR4 agonist. This supports
the reports that P. gingivalis drives a chronic inflammatory
response via activation of TLR2 and inhibition of TLR4 in
immune cells (7). TLR2-mediated activation is relevant in the
context of pathogen induced atheroma formation in mice (31).
The induced two-fold increase in IL-6 and TNFa production by P.
gingivalis was comparable but lower compared to the effect size of
oxLDL (see Figure 1D for oxLDL training) and BCG (13, 28). P.
gingivalis did not significantly induce foam cell formation in
macrophages, possibly due to the sample size. In mice, direct
stimulation with P. gingivalis did increase foam cell formation




FIGURE 4 | Periodontal, vascular wall inflammation and hematopoietic tissue activation on [18F]FDG PET/CT scan. Standard uptake value (SUV) of each region in
control participants (white bars, n=14) and participants with periodontitis (black bars, n=14). Regions of interest are illustrated in the figure with black lines/blocks.
(A) Periodontal [18F]FDG-uptake (SUVmean), (B) Vascular wall [
18F]FDG-uptake (SUVmean), and (C) Hematopoietic [
18F]FDG-uptake (SUVmean). Raw data is shown as
geometric mean with 95% CI, and p-values are age corrected with ANCOVA.
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from healthy blood donors. Their periodontitis status and
cardiovascular risk factors are unknown which could potentially
act as confounding factors. Nevertheless, despite the possible
confounders of the donors, we found an significant trained
immunity response to P. gingivalis. Future experiments should
elucidate the cellular mechanisms by which P. gingivalis induces
trained immunity. Together this suggests that trained immunity
might fuel a self-perpetuating chronic inflammation in
the periodontium.
Our second aim was to translate our in vitro findings to
patients with periodontitis in vivo. In this study, participants
were included with PD based on validated clinical index and
radiographs. Although we aimed to match the patient and
control group, age was significantly different and subsequently
all results were corrected for age. In this exploratory study, we
presented our data before (i.e. raw data) and after age correction.
In contrast to the in vitro results of PG-induced trained
immunity, no difference in the cytokine production capacity of
circulating monocytes, which is regarded as major indicator of
trained immunity, between individuals with severe PD and those
without was observed. This is in contrast to previous studies that
did show trained immunity characteristics in vivo: after BCG
vaccination in vivo, isolated monocytes show a hyperresponsive
trained phenotype for several months after vaccination (28).
Also, isolated monocytes from subjects with dyslipidemia or
pheochromocytoma show a trained phenotype, matching the in
vitro observations that oxLDL and catecholamines induce
trained immunity (33). There are various explanations for this
discrepancy between the in vitro and in vivo findings in the
current study. First, in comparison to BCG vaccination and
pheochromocytoma that have systemic effects, PD is a local
disease which might not influence the phenotype of circulating
immune cells. Secondly, the disease severity in our patient group
might not be severe enough to exert a significant effect on distant
immune cells. Thirdly, the in vitro training effect of P. gingivalis
might be diluted in vivo by influences of other stimuli. Our
results do not exclude, however, that trained immunity by P.
gingivalis occurs locally in the inflamed periodontium, or within
atherosclerotic plaques.
It is worth to emphasize that our patients with severe PD had
signs of systemic inflammation, with significantly higher
circulating leukocytes, supporting the existing evidence for the
presence of systemic inflammation in PD (2). In detail, tSNE
analysis revealed a lower subset of T-lymphocytes with platelet
interaction in PD. The role of lymphocytes in the development of
periodontitis in an interesting topic for future research. To test
the hypothesis that the mechanism of trained immunity could
contribute to the development of CVD by augmenting the
inflammatory component of atherosclerosis in patients with
periodontitis, we assessed vascular wall inflammation by PET-
CT scanning. A trend for periodontal and hematopoietic tissue
activation was observed. Moreover, positive correlations between
the severity of PD and circulating inflammatory markers or
vascular wall inflammation were found. The mild association
with vascular inflammation was only observed in iliac arteries,
which is a region that is prone for early atherosclerotic plaque
development. There are only a few studies using PET-CT
scanning that show that periodontal [18F]FDG-uptake
correlates with vascular wall inflammation (34), and that lipid-
lowering therapy significantly decreases vascular wall
inflammation as well as periodontal inflammation (35).
However, major limitations of these studies are that
participants were retrospectively selected from other cohorts
without clinical diagnosis of PD.
Limitations of the Study
What makes our study unique is that key factors involved in the
etiology and pathogenesis of PD, including P. gingivalis as
keystone pathogen and the host innate immune response, were
investigated together, in detail, and prospective in relation to
atherosclerotic inflammation. Highly sensitive methods for
evaluation of innate immune cells were used, and [18F]FDG
PET/CT scanning was applied for bone marrow, periodontal and
vascular wall inflammation. Limitations are the small sample size
(n=14 per group) and that participants with severe PD were in
supportive periodontal therapy, which resulted in a milder
phenotype. It cannot be excluded this influenced our results, as
periodontal therapy can reduce surrogate markers of CVD (2).
Together, this may explain the lack of differences in cytokine
production capacity and vascular wall inflammation. Larger
cross-sectional studies with untreated cases of severe PD are
needed to further explore trained immunity in this population.
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